In experiments in Lcn2-deficient mice fed with a high fat diet to induce experimental steatosis, it was shown that the lack of LCN2 expression significantly potentiated diet-induced obesity, dyslipidemia, FLD, and insulin resistance (Guo et al., 2010). This evidence concerns the gene LCN2 and metabolic syndrome.